2012
DOI: 10.1016/j.jdermsci.2011.12.002
|View full text |Cite
|
Sign up to set email alerts
|

The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(33 citation statements)
references
References 27 publications
0
32
0
1
Order By: Relevance
“…In a study on SJS-TEN, Tregs isolated from patients with acute-stage TEN were found to be profoundly impaired in their suppressive function, which may be related to severe epidermal damage (49). Another recent study also revealed that the drug-specific Tregs proliferated during the recovery stage in 1 SCAR patient (50). Furthermore, several studies indicated that the expression levels of FOXP3 and the suppressive functions of Tregs were increased by anti-TNF-α treatment (51,52).…”
Section: Study Proceduresmentioning
confidence: 99%
“…In a study on SJS-TEN, Tregs isolated from patients with acute-stage TEN were found to be profoundly impaired in their suppressive function, which may be related to severe epidermal damage (49). Another recent study also revealed that the drug-specific Tregs proliferated during the recovery stage in 1 SCAR patient (50). Furthermore, several studies indicated that the expression levels of FOXP3 and the suppressive functions of Tregs were increased by anti-TNF-α treatment (51,52).…”
Section: Study Proceduresmentioning
confidence: 99%
“…The drug hypersensitivity syndrome caused by abacavir is strongly associated with HLA-B*5701, and key structures in the peptide-binding cleft of HLA-B*5701 have been identified that permit non-covalent interactions with this drug [134][135][136]. This binding may also occur in so-called empty, non-peptide bearing MHC class I molecules.…”
Section: Hla and Drug Sensitivitymentioning
confidence: 99%
“…Several assays to detect drug-specific T cells employing FCM are currently in use and have been described in the literature (10)(11)(12). CD69 is one of the specific markers for T-cell activation other than CD40L, and upregulation of this surface-specific marker was reportedly detected after 48 h in LTT-positive patients (8).…”
Section: Discussionmentioning
confidence: 99%